← Eichor
Study identifier: NCT04506853 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Single-Sided Deafness and Asymmetric Hearing Loss

Condition: Hearing Loss, Unilateral · Hearing Loss, Sensorineural  ·  Sponsor: Med-El Corporation

PhaseNA
Planned participants65
Who can joinAll sexes, 5 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of the study is to evaluate the long-term safety and effectiveness of cochlear implantation of the approved population in adults and children with single-sided deafness and asymmetric hearing loss.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (6)

Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, Illinois, United StatesWithdrawn
University of IowaIowa City, Iowa, United StatesRecruiting
New York Eye and Ear InfirmaryNew York, New York, United StatesRecruiting
University of North CarolinaChapel Hill, North Carolina, United StatesActive Not Recruiting
Virginia Mason Medical CenterSeattle, Washington, United StatesRecruiting
Sunnybrook Health Sciences CenterToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04506853